Literature DB >> 2571720

Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.

R E Solomon1, M J Brody, G F Gebhart.   

Abstract

The effects on nociception, blood pressure and heart rate of clonidine administered intrathecally to the lumbar level were determined in conscious rats and in rats anesthetized lightly with pentobarbital. In anesthetized rats, intrathecal (i.t.) clonidine (3.2-32.0 micrograms) inhibited the nociceptive tail-flick reflex and had biphasic effects on blood pressure; lesser doses (1.0-10.0 micrograms) produced depressor effects, whereas a greater dose (32.0 micrograms) produced a marked pressor response. Clonidine also produced biphasic effects on blood pressure in conscious rats, with the dose-response function shifted upward and to the left of that observed in anesthetized rats. The depressor and antinociceptive effects of 3.2 micrograms of clonidine were antagonized by pretreatment with yohimbine (30.0 micrograms i.t.) but not by prazosin (30.0 micrograms i.t.) or by yohimbine (0.1 mg/kg i.v.). Thus, these effects of clonidine are mediated by spinal alpha-2 adrenoceptors. The pressor response to 32.0 micrograms of clonidine (i.t., lumbar) was accompanied by marked bradycardia, and similar cardiovascular effects were observed when this dose of clonidine was administered either i.v. or to the cervical level of the spinal cord. The pressor response to 32.0 micrograms of clonidine (i.t., lumbar) was not reduced significantly by i.t. pretreatment with yohimbine (30.0 micrograms) or prazosin (30.0 micrograms), but was diminished significantly by i.v. pretreatment with yohimbine (1.0 mg/kg), prazosin (0.1 mg/kg) or phentolamine (2.0 mg/kg). Neither chlorisondamine (2.5 mg/kg i.v.) or the V1-vasopressin receptor antagonist [1-(beta-mercapto-beta,beta-cyclopentamethylene propionic acid), 2-(o-methyl)tyrosine]Arg8-vasopressin (10.0 micrograms/kg i.v.) reduced the clonidine-produced pressor response. After i.t. injection of 32.0 micrograms of [3H]clonidine, peak levels of radioactivity in the blood were observed at 2 min and corresponded to a blood concentration of 38.8 ng/ml. Injection of an i.v. bolus dose (2.5 micrograms/kg) sufficient to produce these blood levels resulted in a transient pressor response. These results suggest that after i.t. administration of greater doses of clonidine, sufficient amounts of the drug are rapidly redistributed systemically to produce pressor effects by stimulation of vascular alpha adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571720

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  [Epidural and intrathecal administration of alpha 2-adreno-ceptor agonists for postoperative pain relief].

Authors:  M G Rockemann; W Seeling
Journal:  Schmerz       Date:  1996-04-25       Impact factor: 1.107

2.  alpha-Adrenoceptor and opioid receptor modulation of clonidine-induced antinociception.

Authors:  F Sierralta; D Naquira; G Pinardi; H F Miranda
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Pharmacokinetic-pharmacodynamic modeling of the effects of clonidine on pain threshold, blood pressure, and salivary flow.

Authors:  H C Porchet; P Piletta; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Spinal 5-HT(2) and 5-HT(3) receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats.

Authors:  Rajan Radhakrishnan; Ellen W King; Janelle K Dickman; Carli A Herold; Natalie F Johnston; Megan L Spurgin; Kathleen A Sluka
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

5.  Potentiated opioid analgesia in norepinephrine transporter knock-out mice.

Authors:  L M Bohn; F Xu; R R Gainetdinov; M G Caron
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

6.  Sympathoinhibitory effects of rilmenidine may be mediated by sites located below the brainstem.

Authors:  F Sannajust; C Barrès; E Koenig-Bérard; J Sassard
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

7.  Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats.

Authors:  F Sannajust; C Cerutti; E Koenig-Bérard; J Sassard
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

8.  The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Authors:  Melanie A Paquette; Katherine Foley; Elizabeth G Brudney; Charles K Meshul; Steven W Johnson; S Paul Berger
Journal:  Psychopharmacology (Berl)       Date:  2009-03-13       Impact factor: 4.530

9.  Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects.

Authors:  Laura S Stone; Jonathan P German; Kelly F Kitto; Carolyn A Fairbanks; George L Wilcox
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

10.  Endogenous analgesic action of the pontospinal noradrenergic system spatially restricts and temporally delays the progression of neuropathic pain following tibial nerve injury.

Authors:  S W Hughes; L Hickey; R P Hulse; B M Lumb; A E Pickering
Journal:  Pain       Date:  2013-05-14       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.